|
It was reported that a patient had surgery for an abscess on (b)(6) 2018.While hospitalized, the patient was treated with 10 ml bd¿ pre-filled normal saline syringes, in 10 ml syringe with bd¿ blunt plastic cannula.The patient was released and prescribed 10 ml bd¿ pre-filled normal saline syringes, in 10 ml syringe with bd¿ blunt plastic cannula as well.The patient also had several blood and other tests at the hospital.Ultimately, the patient expired from sepsis on (b)(6) 2018.Out of an abundance of caution and in the interest of public health, bd voluntarily recalled certain lots of bd posiflush¿ heparin lock flush and bd¿ pre-filled normal saline flush syringes due to a potential for contamination with serratia marcescens bacterium.Bd was notified by the u.S.Food and drug administration (fda) and (b)(4) about a potential epidemiological link between catheter related blood stream infections and the s.Marcescens bacterium.Specifically, the fda and (b)(4) identified a potential connection between reports of infection in a small number of patients caused by s.Marcescens across multiple states.(b)(4)'s initial investigation found that affected patients had received treatment using certain bd flush products.To date, there is no evidence of bd flush product testing positive for this bacterium.Investigations are ongoing by bd, fda, and (b)(4).
|
|
As both a lot number and sample were unavailable for this incident, a full investigation consisting of a sample analysis and a device history record review could not be completed.Prior to april 2018, there was no trend for infection regarding the bd (b)(4) products.Upon the increase of infection reports beginning in april 2018, a corrective and preventive action plan (capa (b)(4)) was initiated to address the issue.A review of all lot sterility testing performed for product released between april 2015 and may 2018 confirmed that no organism growth was identified for any lots released during the shelf life of this product.A direct causation between the reported infections and the bd franklin product has not been identified.
|